Page 148 - Human Use News Today

BASEL, Switzerland and NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer (NYSE: PFE) announced today an update on the...

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company) a leader in the development of targeted radiotherapies for...

A prime opportunity for China’s domestic drug development industry to capitalise on the growing need for new therapeutics.

/PRNewswire/ -- The board of directors of Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group",Stock code:2179.HK)...

/PRNewswire/ -- Priothera Ltd, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator mocravimod, today announces...

Adjuvanted H5N1 influenza vaccine has been shown to be highly immunogenic in younger and older adults. It is being developed in light of a possible H5N1 influenza pandemic that could cause global harm.

Is a sense of moral and intellectual superiority. thats what msnbc has become. people tune in to know they know better and smarter than the dumb right wingers taking horse dewormers. no one was doing that. there is a human use for that. they arent there for an honest confirmation but confirmation bias, we know better even when they dont. >> lets switch to this. amazon saying it has reprogrammed alexa after a mothers story about a major malfunction went viral. her 10-year-old asked alexa to come ...

Guidelines released in late March by China’s State Council, the country’s top governing body, state something that might sound surprising to outsiders: that research ethics should reflect national identity.

PRESS RELEASE European Commission Approves KIMMTRAK® (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma KIMMTRAK is the first...

/PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), today announced that data from a Phase 1, single-center, open-label study evaluating...